AERI Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 nov 2022 @ 22:00):

Stats
Dagens volum	1.22M
Gjennomsnittsvolum	786 842
Markedsverdi	0.00
EPS	$-0.560 ( Q3 \| 2022-11-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 30.78
ATR14	$0.0770 (0.50%)

AERI 0.00%

ALVO 1.33%

ALVOW 6.79%

BDSI -0.09%

BFRIW -5.93%

CLVRW 0.00%

CYTHW -4.35%

ENDP 0.00%

GRVI 7.61%

HPCO 0.06%

INDV -1.59%

JUPWW -20.00%

LFCR -0.19%

LNDC -3.52%

LSDI -23.29%

PRFX -3.65%

PROCW 10.09%

QLI 6.82%

SBFMW 0.00%

SHOT 9.43%

SHPH 4.28%

Insider Trading

Date	Person	Action	Amount	type
2022-11-21	Mchugh Julie	Sell	16 854	Stock Option (right to buy)
2022-11-21	Mcgraw Benjamin F Iii	Sell	16 854	Stock Option (right to buy)
2022-11-21	Mcdonnell Peter J	Sell	16 854	Stock Option (right to buy)
2022-11-21	Kopczynski Casey C.	Sell	65 941	Stock Option (right to buy)
2022-11-21	Lang Peter Frederick	Sell	160 551	Stock Option (right to buy)

INSIDER POWER
-99.57
Last 98 transactions
Buy: 1 757 162 \| Sell: 988 060

Volum Korrelasjon

Lang: 0.16 (neutral)

Kort: 0.47 (neutral)

Signal:(68.342) Neutral

Aerie Pharmaceuticals, Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Aerie Pharmaceuticals, Korrelasjon - Valuta/Råvare

-0.81
( strong negative )

-0.94
( very strong negative )

-0.89
( strong negative )

-0.03
( neutral )

0.85
( strong )

0.70
( moderate )

Aerie Pharmaceuticals, Økonomi

Annual	2021
Omsetning:	$194.13M
Bruttogevinst:	$167.29M (86.17 %)
EPS:	$-1.610

FY	2021
Omsetning:	$194.13M
Bruttogevinst:	$167.29M (86.17 %)
EPS:	$-1.610

FY	2020
Omsetning:	$83.14M
Bruttogevinst:	$57.81M (69.53 %)
EPS:	$-3.99

FY	2019
Omsetning:	$69.89M
Bruttogevinst:	$65.06M (93.08 %)
EPS:	$-4.39

Financial Reports:

No articles found.

Aerie Pharmaceuticals, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aerie Pharmaceuticals,

Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.